Viewing Study NCT03400592


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2025-12-26 @ 9:59 AM
Study NCT ID: NCT03400592
Status: UNKNOWN
Last Update Posted: 2018-01-17
First Post: 2015-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module